Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings
Open Access
- 1 September 2005
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (9), 3676-3681
- https://doi.org/10.1128/aac.49.9.3676-3681.2005
Abstract
Linezolid is a new antimicrobial agent effective against drug-resistant gram-positive pathogens which are common causes of infections in hospitalized patients. Many such patients rely on the intravenous or enteral route for nutrition and drug administration. Therefore, the bioavailability of linezolid administered enterally in the presence of enteral feedings in hospitalized patients was examined. Eighteen subjects were assessed in a randomized single-dose crossover study; 12 received continuous enteral feedings, while 6 did not (controls). Both groups received linezolid 600 mg intravenously and orally (control) or enterally, with the alternate route of administration separated by a 24-h washout period. Pharmacokinetic parameters derived from noncompartmental and compartmental analysis incorporating linear and nonlinear elimination pathways were compared between groups: F , K a , V s , K 23 , K 32 , V max , K m , and K 2 0 (bioavailability, absorption rate constant, volume of central compartment normalized to body weight, intercompartmental rate constants, maximum velocity, Michaelis-Menten constant, and elimination rate constant, respectively). Pharmacokinetic (PK) data were available from 17 patients. The linezolid oral suspension was rapidly and completely absorbed by either the oral or enteral route of administration. Bioavailability was unaltered in the presence of enteral feedings. PK estimates remain similar regardless of the model applied. At the therapeutic dose used, only slight nonlinearity in elimination was observed. A linezolid oral suspension may be administered via the enteral route to hospitalized patients without compromise in its excellent bioavailability and rapid rate of absorption. Compartmental pharmacokinetic analysis offers a more flexible study application, since bioavailability ( F ) can be estimated directly with intermixed intravenous/oral doses without a need for a washout period.Keywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2003
- Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteersJournal of Antimicrobial Chemotherapy, 2003
- Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use ProgramAntimicrobial Agents and Chemotherapy, 2003
- Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone AntibacterialClinical Pharmacokinetics, 2003
- Age and sex effects on the pharmacokinetics of linezolidEuropean Journal of Clinical Pharmacology, 2001
- Linezolid absolute bioavailability and the effect of food on oral bioavailabilityBiopharmaceutics & Drug Disposition, 2001
- The Changing Epidemiology of Staphylococcus aureus?Emerging Infectious Diseases, 2001
- Bioavailability of Fluconazole in Surgical Intensive Care Unit PatientsThe Journal of Trauma and Acute Care Surgery, 1995
- Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacinAntimicrobial Agents and Chemotherapy, 1994
- A computer program for estimation of creatinine clearance from unstable serum creatinine levels, age, sex, and weightMathematical Biosciences, 1972